{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:16:12Z","timestamp":1792440972761,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.medmal.2018.01.004","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T13:11:26Z","timestamp":1518527486000},"page":"238-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Use of artesunate in non-malarial indications"],"prefix":"10.1016","volume":"48","author":[{"given":"A.","family":"Raffetin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bruneel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Thellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Caumes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jaur\u00e9guiberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.medmal.2018.01.004_bib0330","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","article-title":"The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine","volume":"17","author":"Tu","year":"2011","journal-title":"Nat Med"},{"issue":"9487","key":"10.1016\/j.medmal.2018.01.004_bib0335","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","article-title":"Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial","volume":"366","author":"Dondorp","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2018.01.004_bib0340","series-title":"Guidelines for the treatment of malaria","first-page":"194","year":"2010"},{"key":"10.1016\/j.medmal.2018.01.004_bib0345","article-title":"Management and prevention of imported malaria (Revision 2017 of the 2007 Recommandations for clinical practice). Long text","author":"Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise","year":"2017","journal-title":"Med Mal Infect"},{"issue":"10","key":"10.1016\/j.medmal.2018.01.004_bib0350","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tips.2008.07.004","article-title":"Artemisinins: their growing importance in medicine","volume":"29","author":"Krishna","year":"2008","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.medmal.2018.01.004_bib0355","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pt.2010.11.006","article-title":"Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets","volume":"27","author":"Ding","year":"2011","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.medmal.2018.01.004_bib0360","first-page":"1","article-title":"The potential therapeutic effects of artesunate on stroke and other central nervous system diseases","volume":"2016","author":"Zuo","year":"2016","journal-title":"Bio Med Res Int"},{"issue":"1","key":"10.1016\/j.medmal.2018.01.004_bib0365","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.medmal.2018.01.004_bib0370","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.medmal.2018.01.004_bib0375","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2016.11.012","article-title":"Artemisinin and its derivatives in treating protozoan infections beyond malaria","volume":"117","author":"Loo","year":"2017","journal-title":"Pharmacol Res"},{"issue":"3","key":"10.1016\/j.medmal.2018.01.004_bib0380","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1469-0691.2009.03131.x","article-title":"Acute schistosomiasis, a diagnostic and therapeutic challenge","volume":"16","author":"Jaur\u00e9guiberry","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"18","key":"10.1016\/j.medmal.2018.01.004_bib0385","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2217\/pgs.16.23","article-title":"Genome-wide miRNAs expression profiles of Schistosoma japonicum schistosomula in response to artesunate","volume":"17","author":"Kong","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.medmal.2018.01.004_bib0390","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.phrs.2016.02.017","article-title":"Antischistosomal activity of artemisinin derivatives in vivo and in patients","volume":"110","author":"Saeed","year":"2016","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.medmal.2018.01.004_bib0395","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QCO.0b013e3282f19ec4","article-title":"Artemisinins and synthetic trioxolanes in the treatment of helminth infections","volume":"20","author":"Keiser","year":"2007","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.medmal.2018.01.004_bib0400","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00436-013-3724-5","article-title":"Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum","volume":"113","author":"Wang","year":"2014","journal-title":"Parasitol Res"},{"issue":"1","key":"10.1016\/j.medmal.2018.01.004_bib0405","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00436-013-3647-1","article-title":"Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum?","volume":"113","author":"Wang","year":"2014","journal-title":"Parasitol Res"},{"issue":"5","key":"10.1016\/j.medmal.2018.01.004_bib0410","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s00436-013-3358-7","article-title":"Haemin enhances the in vivo efficacy of artemether against juvenile and adult Schistosoma mansoni in mice","volume":"112","author":"El-Lakkany","year":"2013","journal-title":"Parasitol Res"},{"issue":"9","key":"10.1016\/j.medmal.2018.01.004_bib0415","doi-asserted-by":"crossref","first-page":"e45867","DOI":"10.1371\/journal.pone.0045867","article-title":"Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis","volume":"7","author":"P\u00e9rez del Villar","year":"2012","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.medmal.2018.01.004_bib0420","doi-asserted-by":"crossref","first-page":"e2975","DOI":"10.1371\/journal.pntd.0002975","article-title":"Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial","volume":"8","author":"Keiser","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.medmal.2018.01.004_bib0425","first-page":"CD280005","article-title":"Drugs for treating Schistosoma mansoni infection","volume":"2","author":"Danso-Appiah","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.medmal.2018.01.004_bib0430","first-page":"CD000053","article-title":"Drugs for treating urinary schistosomiasis","author":"Kramer","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.medmal.2018.01.004_bib0435","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/jtm.12043","article-title":"Asymptomatic Schistosoma haematobium infection in a traveler with negative urine microscopy and late seroconversion presumably linked to Artesunate","volume":"20","author":"Martinez-Calle","year":"2013","journal-title":"J Trav Med"},{"issue":"4","key":"10.1016\/j.medmal.2018.01.004_bib0440","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00436-010-1944-5","article-title":"The sensitivity of artesunate against Schistosoma japonicum decreased after 10 years of use in China","volume":"107","author":"Hua","year":"2010","journal-title":"Parasitol Res"},{"issue":"9","key":"10.1016\/j.medmal.2018.01.004_bib0445","doi-asserted-by":"crossref","first-page":"e1285","DOI":"10.1371\/journal.pntd.0001285","article-title":"Efficacy and safety of artemether in the treatment of chronic fascioliasis in Egypt: exploratory phase-2 trials","volume":"5","author":"Keiser","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.medmal.2018.01.004_bib0450","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijantimicag.2009.03.013","article-title":"Artesunate plus sulfamethoxypyrazine\/pyrimethamine for the treatment of cutaneous leishmaniasis: a double-blind, placebo-controlled clinical trial","volume":"34","author":"Adam","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.medmal.2018.01.004_bib0455","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.medmal.2018.01.004_bib0460","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/bmt.2012.46","article-title":"Evidence for clinical activity of artesunate in multidrug-resistant herpes simplex infection following HSCT","volume":"47","author":"Sellar","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.medmal.2018.01.004_bib0465","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2005.10.003","article-title":"The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo","volume":"69","author":"Kaptein","year":"2006","journal-title":"Antiviral Res"},{"issue":"6","key":"10.1016\/j.medmal.2018.01.004_bib0470","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3851\/IMP3028","article-title":"Artesunate demonstrates in vitro synergism with several antiviral agents against human cytomegalovirus","volume":"21","author":"Drouot","year":"2016","journal-title":"Antivir Ther"},{"issue":"9","key":"10.1016\/j.medmal.2018.01.004_bib0475","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/587106","article-title":"Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation","volume":"46","author":"Shapira","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.01.004_bib0480","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2013.10.014","article-title":"Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus","volume":"101","author":"Germi","year":"2014","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.medmal.2018.01.004_bib0485","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/tid.12435","article-title":"Combination therapy for multidrug-resistant cytomegalovirus disease","volume":"17","author":"Stuehler","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.medmal.2018.01.004_bib0490","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.antiviral.2011.03.184","article-title":"Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation","volume":"90","author":"Wolf","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.medmal.2018.01.004_bib0495","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcv.2016.02.006","article-title":"Effect of artemether-lumefantrine (Coartem) on cytomegalovirus urine viral load during and following treatment for malaria in children","volume":"77","author":"Barger-Kamate","year":"2016","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.medmal.2018.01.004_bib0500","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jcv.2013.06.008","article-title":"An artesunate-containing antimalarial treatment regimen did not suppress cytomegalovirus viremia","volume":"58","author":"Gantt","year":"2013","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.medmal.2018.01.004_bib0505","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504605","article-title":"Effect of artesunate-amodiaquine on mortality related to Ebola virus disease","volume":"374","author":"Gignoux","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.medmal.2018.01.004_bib0510","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/AAC.04229-14","article-title":"Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms","volume":"59","author":"De Cremer","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.medmal.2018.01.004_bib0515","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11046-011-9445-3","article-title":"Transcriptomic and proteomic profile of Aspergillus fumigatus on exposure to artemisinin","volume":"172","author":"Gautam","year":"2011","journal-title":"Mycopathologia"},{"issue":"4","key":"10.1016\/j.medmal.2018.01.004_bib0520","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jac\/dkr017","article-title":"Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC","volume":"66","author":"Li","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.medmal.2018.01.004_bib0525","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.intimp.2007.10.024","article-title":"Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation","volume":"8","author":"Li","year":"2008","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10.1016\/j.medmal.2018.01.004_bib0530","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ja.2013.22","article-title":"Artesunate has its enhancement on antibacterial activity of \u03b2-lactams via increasing the antibiotic accumulation within methicillin-resistant Staphylococcus aureus (MRSA)","volume":"66","author":"Jiang","year":"2013","journal-title":"J Antibiot"},{"issue":"8","key":"10.1016\/j.medmal.2018.01.004_bib0535","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.intimp.2011.02.028","article-title":"Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin","volume":"11","author":"Jiang","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.medmal.2018.01.004_bib0540","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fmicb.2016.00743","article-title":"A drug combination screen identifies drugs active against amoxicillin-induced round bodies of in vitro Borrelia burgdorferi persisters from an FDA Drug Library","volume":"7","author":"Feng","year":"2016","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.medmal.2018.01.004_bib0545","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/cid\/cit810","article-title":"A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease","volume":"58","author":"Lantos","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.01.004_bib0550","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mehy.2017.06.015","article-title":"The effect of artesunate on short-term memory in Lyme borreliosis","volume":"105","author":"Puri","year":"2017","journal-title":"Med Hypotheses"},{"issue":"14","key":"10.1016\/j.medmal.2018.01.004_bib0555","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1016\/j.bmc.2013.04.059","article-title":"Novel artemisinin derivatives with potential usefulness against liver\/colon cancer and viral hepatitis","volume":"21","author":"Blazquez","year":"2013","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10.1016\/j.medmal.2018.01.004_bib0560","doi-asserted-by":"crossref","first-page":"502","DOI":"10.18632\/oncotarget.969","article-title":"A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the international initiative for accelerated improvement of glioblastoma care","volume":"4","author":"Kast","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.medmal.2018.01.004_bib0565","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","article-title":"New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids","volume":"97","author":"Reiter","year":"2015","journal-title":"Eur J Med Chem"},{"issue":"7","key":"10.1016\/j.medmal.2018.01.004_bib0570","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1021\/acscentsci.7b00156","article-title":"Mechanistic investigation of the specific anticancer property of artemisinin and its combination with aminolevulinic acid for enhanced anticolorectal cancer activity","volume":"3","author":"Wang","year":"2017","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.medmal.2018.01.004_bib0575","doi-asserted-by":"crossref","first-page":"45874","DOI":"10.18632\/oncotarget.17437","article-title":"Combined treatment with artesunate and bromocriptine has synergistic anticancer effects in pituitary adenoma cell lines","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.medmal.2018.01.004_bib0580","first-page":"200","article-title":"Antitumor effects of artesunate on human breast carcinoma MCF-7 cells and IGF-IR expression in nude mice xenografts","volume":"26","author":"Dong","year":"2014","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.medmal.2018.01.004_bib0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: artemisia annua and artemisinin for cancer therapy","author":"Efferth","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.medmal.2018.01.004_bib0590","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","article-title":"Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis","volume":"11","author":"Roh","year":"2017","journal-title":"Redox Biol"},{"issue":"8","key":"10.1016\/j.medmal.2018.01.004_bib0595","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1371\/journal.pone.0000798","article-title":"Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate","volume":"2","author":"Kelter","year":"2007","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.medmal.2018.01.004_bib0600","first-page":"1599","article-title":"Artesunate in the treatment of metastatic uveal melanoma\u00a0\u2013\u00a0first experiences","volume":"14","author":"Berger","year":"2005","journal-title":"Oncol Rep"},{"issue":"2","key":"10.1016\/j.medmal.2018.01.004_bib0605","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3736\/jcim20080206","article-title":"[Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial]","volume":"6","author":"Zhang","year":"2008","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"issue":"1","key":"10.1016\/j.medmal.2018.01.004_bib0610","first-page":"82","article-title":"A randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer","volume":"2","author":"Krishna","year":"2015","journal-title":"EBio Med"},{"issue":"2","key":"10.1016\/j.medmal.2018.01.004_bib0615","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-017-4261-1","article-title":"Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33\/2)","volume":"164","author":"von Hagens","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"10.1016\/j.medmal.2018.01.004_bib0620","first-page":"4417","article-title":"First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers","volume":"31","author":"Jansen","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.medmal.2018.01.004_bib0625","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pharmthera.2016.07.002","article-title":"Immune suppressive properties of artemisinin family drugs","volume":"166","author":"Hou","year":"2016","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.medmal.2018.01.004_bib0630","doi-asserted-by":"crossref","first-page":"e32424","DOI":"10.1371\/journal.pone.0032424","article-title":"SM934 treated lupus-prone NZB\u00d7NZW F1 mice by enhancing macrophage Interleukin-10 production and suppressing pathogenic T cell development","volume":"7","author":"Hou","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.medmal.2018.01.004_bib0635","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.bjp.0707137","article-title":"Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation","volume":"150","author":"Wang","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"11","key":"10.1016\/j.medmal.2018.01.004_bib0640","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.phymed.2016.06.004","article-title":"Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines","volume":"23","author":"Jiang","year":"2016","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.medmal.2018.01.004_bib0645","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/cns.12066","article-title":"Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe\/PS1dE9 transgenic mice via inhibition of nuclear factor-\u03baB and NLRP3 inflammasome activation","volume":"19","author":"Shi","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.medmal.2018.01.004_bib0650","series-title":"Artesunate in treatment of dermatosis","author":"Yu","year":"1997"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17310338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17310338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:16:21Z","timestamp":1759972581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X17310338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0399077X17310338"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2018.01.004","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of artesunate in non-malarial indications","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2018.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}